Chugai Pharmaceutical (CHGCY) Earnings Date, Estimates & Call Transcripts

$15.85
+0.20 (+1.28%)
(As of 05:34 PM ET)

Earnings Summary

Latest
Earnings Date
Feb. 1Estimated
Actual EPS
(Feb. 1)
$0.19 Beat By $0.01
Consensus EPS
(Feb. 1)
$0.18
Skip Charts & View Estimated and Actual Earnings Data

CHGCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CHGCY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Chugai Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.70 EPS
Next Year EPS Consensus Estimate: $0.74 EPS

CHGCY Earnings Date and Information

Chugai Pharmaceutical last released its quarterly earnings data on February 1st, 2024. The reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.01. The business earned $1.85 billion during the quarter. Chugai Pharmaceutical has generated $0.68 earnings per share over the last year ($0.68 diluted earnings per share) and currently has a price-to-earnings ratio of 23.3. Earnings for Chugai Pharmaceutical are expected to grow by 5.71% in the coming year, from $0.70 to $0.74 per share.

Chugai Pharmaceutical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/1/2024Q4 2023$0.18$0.19+$0.01$0.19-$1.85 billion
10/24/2023Q3 2023-$0.16+$0.16$0.16-$1.78 billion  
7/27/2023Q2 2023-$0.18+$0.18$0.18-$1.95 billion
4/27/2023Q1 2023-$0.17+$0.17$0.17-$2.36 billion
2/2/2023Q4 2022-$0.22+$0.22$0.22$3.24 billion$3.11 billion
10/24/2022Q3 2022$0.17$0.15($0.02)$0.15$1.89 billion$1.63 billion
7/21/2022Q2 2022-$0.17+$0.17$0.17$2.46 billion$1.82 billion
4/25/2022Q1 2022-$0.34+$0.34$0.34-$3.10 billion
2/3/2022Q4 2021-$0.26+$0.26$0.26-$2.84 billion
10/22/2021Q3 2021-$0.24+$0.24$0.24-$2.61 billion
7/26/2021Q2 2021-$0.20+$0.20$0.20-$2.08 billion

Chugai Pharmaceutical Earnings - Frequently Asked Questions

When did Chugai Pharmaceutical announce their last quarterly earnings?

Chugai Pharmaceutical (OTCMKTS:CHGCY) last announced its quarterly earning data on Thursday, February 1, 2024. Learn more on CHGCY's earnings history.

Did Chugai Pharmaceutical beat their earnings estimates last quarter?

In the previous quarter, Chugai Pharmaceutical (OTCMKTS:CHGCY) reported $0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $0.18 by $0.01. Learn more on analysts' earnings estimate vs. CHGCY's actual earnings.

How much revenue does Chugai Pharmaceutical generate each year?

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a recorded annual revenue of $7.93 billion.

How much profit does Chugai Pharmaceutical generate each year?

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a recorded net income of $2.31 billion. CHGCY has generated $0.68 earnings per share over the last four quarters.

What is Chugai Pharmaceutical's price-to-earnings ratio?

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a trailing price-to-earnings ratio of 23.31 and a forward price-to-earnings ratio of 22.64.

What is Chugai Pharmaceutical's EPS forecast for next year?

Chugai Pharmaceutical's earnings are expected to grow from $0.70 per share to $0.74 per share in the next year, which is a 5.71% increase.


More Earnings Resources from MarketBeat

This page (OTCMKTS:CHGCY) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners